US$ 23.85
ghk-cu wound healing clinical trial human Dosage: Protocols & Charts GHK-Cu Dosing: 1.7mg/Day Injectable (2026)
Description
Moreover, the diagnostic criteria for GHD are not uniform worldwide 2

Several approaches work effectively: Once Daily Protocol: A single morning dose of 0.1 to 0.15 mg provides simplicity and good results for most chronic conditions

Research Mechanism (Mechanism of Action) NNMT normally catalyses the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide (1-MNA)

Phase Titration Dose 75 mg Frequency 1-3x weekly Notes Increase by ~25 mg if assessment phase is well tolerated
